The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells

By A Mystery Man Writer

trastuzumab- MedChemExpress (MCE) Life Science Reagents

Biomolecules, Free Full-Text

Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth

Recent advances toward the development of Hsp90 C-terminal inhibitors - ScienceDirect

The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells

The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells

Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth

The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive and trastuzumab-resistant breast cancer cells

Detailed curriculum vitae of HER2-targeted therapy - ScienceDirect

©2016-2024, doctommy.com, Inc. or its affiliates